Stringent rosiglitazone-dependent gene switch in muscle cells without effect on myogenic differentiation

Molecular Therapy

Volumn 9, Issue 5, 2004, Pages 637-649

  Tascou, Semi ^a   Sorensen, Tine Kring ^a   Glénat, Valérie ^a,b   Wang, Manping ^a,c   Lakich, Mélissa M ^a,d   Darteil, Raphaël ^a,e   Vigne, Emmanuelle ^a   Thuillier, Vincent ^a  

^a Gencell SAS   (France)

^b SANOFI   (France)

^c Cytokinetics Inc   (United States)

^d EXELIXIS INC   (United States)

^e Genfit Parc Eurasante Lille Metro   (France)

Author keywords

Adipogenesis; Gene therapy; Muscle; Plasmid; PPAR ; Scaffold matrix attachment region

Indexed keywords

BETA INTERFERON; DNA; LUCIFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLASMID VECTOR; ROSIGLITAZONE; TRANSCRIPTION FACTOR;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL METABOLISM; CONTROLLED STUDY; DNA BINDING; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SWITCHING; GENE THERAPY; GENETIC TRANSCRIPTION; HISTOLOGY; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROMOTER REGION; PROTEIN FUNCTION;

CUCUMBER MOSAIC VIRUS; MURINAE;

EID: 2442681626     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2004.02.013     Document Type: Article

References (41)

1. Harvey, D. M., and Caskey, C. T. (1998). Inducible control of gene expression: prospects for gene therapy. Curr. Opin. Chem. Biol. 2: 512-518.
2. Clackson, T. (2000). Regulated gene expression systems. Gene Ther. 7: 120-125.
3. Latta-Mahieu, M., et al. (2002). Gene transfer of a chimeric trans-activator is immunogenic and results in short-lived transgene expression. Hum. Gene Ther. 13: 1611-1620.
4. Favre, D., et al. (2002). Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus. J. Virol. 76: 11605-11611.
5. Darteil, R., et al. (2002). Efficient gene regulation by PPAR gamma and thiazolidinediones in skeletal muscle and heart. Mol. Ther. 6: 265-271.
6. Mangelsdorf, D. J., et al. (1995). The nuclear receptor superfamily: the second decade. Cell 83: 835-839.
7. Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., and Evans, R. M. (1995). 15-Deoxy-delta 12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83: 803-812.
8. Kliewer, S., et al. (1997). Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc. Natl. Acad. Sci. USA 94: 4318-4323.
9. Nagy, L., Tontonoz, P., Alvarez, J. G., Chen, H., and Evans, R. M. (1998). Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell 93: 229-240.
10. Schoonjans, K., Staels, B., and Auwerx, J. (1996). The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim. Biophys. Acta 1302: 93-109.
11. Kliewer, S., Umesono, K., Noonan, D., Heyman, R., and Evans, R. (1992). Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358: 771-774.
12. Elbrecht, A., et al. (1996). Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. Biochem. Biophys. Res. Commun. 224: 431-437.
13. Escher, P., Braissant, O., Basu-Modak, S., Michalik, L., Wahli, W., and Desvergne, B. (2001). Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding. Endocrinology 142: 4195-4202.
14. Mueller, E., et al. (2002). Genetic analysis of adipogenesis through peroxisome proliferator-activated receptor gamma isoforms. J. Biol. Chem. 277: 41925-41930.
15. Rosen, E. D., et al. (1999). PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell 4: 611-617.
16. Kersten, S., Desvergne, B., and Wahli, W. (2000). Roles of PPARS in health and disease. Nature 405: 421-424.
17. Lehmann, J., Moore, L., Smith, O. T., Wilkison, W., Willson, T., and Kliewer, S. (1995). An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR γ). J. Biol. Chem. 270: 12953-12956.
18. Krey, G., et al. (1997). Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol. 11: 779-791.
19. Guan, H. P., Li, Y., Jensen, M. V., Newgard, C. B., Steppan, C. M., and Lazar, M. A. (2002). A futile metabolic cycle activated in adipocytes by antidiabetic agents. Nat. Med. 8: 1122-1128.
20. Hu, E., Tontonoz, P., and Spiegelman, B. (1995). Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBP alpha. Proc. Natl. Acad. Sci. USA 92: 9856-9860.
21. Hsu, M. H., Palmer, C. N., Song, W., Griffin, K. J., and Johnson, E. F. (1998). A carboxyl-terminal extension of the zinc finger domain contributes to the specificity and polarity of peroxisome proliferator-activated receptor DNA binding. J. Biol. Chem. 273: 27988-27997.
22. Juge-Aubry, C., et al. (1997). DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements: importance of the 5′-flanking region. J. Biol. Chem. 272: 25252-25259.
23. Umesono, K., and Evans, R. M. (1989). Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell 57: 1139-1146.
24. Minty, A., and Kedes, L. (1986). Upstream regions of the human cardiac actin gene that modulate its transcription in muscle cells: presence of an evolutionarily conserved repeated motif. Mol. Cell. Biol. 6: 2125-2136.
25. Aihara, Y., et al. (2000). Cardiac ankyrin repeat protein is a novel marker of cardiac hypertrophy: role of M-CAT element within the promoter. Hypertension 36: 48-53.
26. Stehle, I. M., Scinteie, M. F., Baiker, A., Jenke, A. C., and Lipps, H. J. (2003). Exploiting a minimal system to study the epigenetic control of DNA replication: the interplay between transcription and replication. Chromosome Res. 11: 413-421.
27. Lu, Q. L., Bou-Gharios, G., and Partridge, T. A. (2003). Non-viral gene delivery in skeletal muscle: a protein factory. Gene Ther. 10: 131-142.
28. Abruzzese, R. V., et al. (1999). Ligand-dependent regulation of plasmid-based transgene expression in vivo. Hum. Gene Ther. 10: 1499-1507.
29. Abruzzese, R. V., et al. (2000). Ligand-dependent regulation of vascular endothelial growth factor and erythropoietin expression by a plasmid-based autoinducible Gene-Switch system. Mol. Ther. 2: 276-287.
30. No, D., Yao, T. P., and Evans, R. M. (1996). Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc. Natl. Acad. Sci. USA 93: 3346-3351.
31. Xu, L., et al. (2001). A versatile framework for the design of ligand-dependent, transgene-specific transcription factors. Mol. Ther. 3: 262-273.
32. Ye, X., et al. (1999). Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. Science 283: 88-91.
33. Teboul, L., Gaillard, D., Staccini, L., Inadera, H., Amri, E. Z., and Grimaldi, P. A. (1995). Thiazolidinediones and fatty acids convert myogenic cells into adipose-like cells. J. Biol. Chem. 270: 28183-28187.
34. Hunter, J. G., van Delft, M. F., Rachubinski, R. A., and Capone, J. P. (2001). Peroxisome proliferator-activated receptor gamma ligands differentially modulate muscle cell differentiation and MyoD gene expression via peroxisome proliferator-activated receptor gamma-dependent and -independent pathways. J. Biol. Chem. 276: 38297-38306.
35. Albrektsen, T., Frederiksen, K. S., Holmes, W. E., Boel, E., Taylor, K., and Fleckner, J. (2002). Novel genes regulated by the insulin sensitizer rosiglitazone during adipocyte differentiation. Diabetes 51: 1042-1051.
36. Gerhold, D. L., et al. (2002). Gene expression profile of adipocyte differentiation and its regulation by peroxisome proliferator-activated receptor-gamma agonists. Endocrinology 143: 2106-2118.
37. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
38. Fajas, L., et al. (1997). The organization, promoter analysis, and expression of the human PPARγ gene. J. Biol. Chem. 272: 18779-18789.
39. Schubeler, D., Mielke, C., Maass, K., and Bode, J. (1996). Scaffold/matrix-attached regions act upon transcription in a context-dependent manner. Biochemistry 35: 11160-11169.
40. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. (1990). Basic local alignment search tool. J. Mol. Biol. 215: 403-410.
41. Zuker, M. (2003). Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31: 3406-3415.